It was incredible to see a photo of our SSDP team from our cannabis legalization rally back in October 2022 in front of the White House featured in Rolling Stone! A coalition of Democratic senators and representatives is calling on the Biden administration to finalize its plans to limit marijuana prosecutions at the federal level before he leaves office. Read the article
We are grateful to Psychedelic Alpha for this comprehensive overview of the people behind our effort to challenge the DEA on two psychedelic research chemicals – DOI & DOC. The team can only remain optimistic that the evidence presented was enough to tilt the scale in favor of SSDP/Ramos, and if nothing else that those watching and reading about this
Thank you to The Microdose, an independent journalism newsletter brought to you by the U.C. Berkeley Center for the Science of Psychedelics for covering SSDP’s historic ten-day court hearing with the DEA fighting to keep psychedelic research chemicals DOI & DOC legal. Read the article here.
We are grateful for Reason for shining light on our court case with the DEA, fighting to keep DOI & DOC, two psychedelic research chemicals from becoming Schedule I drugs. SSDP describes the two compounds as “essential research chemicals in pre-clinical psychiatry and neurobiology,” noting that their unscheduled status has made them accessible as tools for studying serotonin receptors. It says DOI,
Thank you for Stupiddope for sharing our advocacy alert to call the White House today for National Day of Action for Cannabis Clemency. Read the article here.
Thanks to Nug Magazine for including SSDP as a leader in cannabis policy reform. Today, the landscape of cannabis activism is diverse, encompassing various organizations and advocacy groups focused on reforming cannabis laws. Organizations like the National Organization for the Reform of Marijuana Laws (NORML), the Marijuana Policy Project (MPP), and Students for Sensible Drug Policy (SSDP) have worked tirelessly
We are grateful to investigative journalist Jack Gorsline on behalf of Psychedelic Alpha for joining SSDP in court with the DEA to dig into the SSDP’s trail with the DEA. Reflecting on events thus far, SSDP/Ramos co-counsel Phelps seemed confident. “I think it went as well as we could have hoped”, he said, adding that he thinks his side’s evidence
Tricycle Day ,a leading psychedelic newsletter, featured SSDP’s Executive Director Kat Murti in their November 17, 2024 edition. We spoke to Kat about why students are the ideal people to fight the War on Drugs, how SSDP is challenging the DEA right now, and what anyone can do to support sensible psychedelic policy. Read the Q&A with Kat here.
SSDP Board Member, Axel Bilbao, returns to the Church & Other Drugs podcast for Part 2 of his story. Tune into the podcast here.
Thanks to Shroomer for placing SSDP’s work to stand against the scheduling of DOI & DOC. “DOI and DOC are two crucial medical tools that have been used safely in laboratories for decades. Together, they have featured in more than 900 research articles and show promise for pain management, combatting anxiety and depression, preventing overdose, and treating substance abuse disorder,”
Thanks to Boulder Weekly for sharing news about our upcoming ten day hearing with the DEA to keep psychedelic research chemicals DOI & DOC legal. DOI and DOC have been used to help study anxiety, depression, substance use disorder and more. The drugs have been cited in more than 900 published studies, according to Murti. In July, SSDP and others sued to
Students for Sensible Drug Policy (SSDP) at Cal State Monterey Bay (CSUMB), led by Maria Fernanda Corral Cervantes was featured in The Lutrinae. For Cervantes, fostering a culture of harm reduction on campus means more than just providing resources–it’s about creating a space where students can discuss their experiences openly. “It’s important for students to have a place to talk
SSDP’s partnership with Overdrive Defense gets mention in The New York Times. Read the article here.
Vibe Science hosts Ryan Alford and Chris Hansen bring listeners on a journey through the evolving world of drug policy. Thank you for inviting SSDP’s Kat Murti and Gina Giorgio onto the podcast to discuss psychedelics, drug policy, and the science of healing. Watch the episode here.
Thank you for the Boston University News Service for their article discussing Question 4 on the Massachusetts ballot. Read the article here. “Typically, the way we approach mental healthcare is through a long path of seeing a therapist for potentially years,” said Gina Giorgio, Director of Strategy for Students for Sensible Drug Policy. “Psychedelic therapists say that treatment may only
Thanks to The Lutrinae, the student-run newspaper covering California State University, Monterey Bay, for posting their article, “Six tips from the Students for Sensible Drug Policy to stay safe during Halloween.“ “While college students may be past their candy-collecting days, unfamiliar substances, chaotic environments and inexperience mean #Halloween can still be as risky as any horror story according to the
Thank you to Lucid News for sharing information about the importance of Question 4 on the ballot in Massachusetts. SSDP’s Campaign Educators have been all over the state urging the community to register to vote, and sharing important info on what this measure means for psychedelic policy in the state. Law Enforcement Action Partnership, veterans groups including Disabled American Veterans
Local advocacy groups including SSDP will host an informal reception at the Garden Cinemas on Sunday, Nov. 3, at 4:30 p.m., to discuss Yes on 4 followed by a screening of the feature-length documentary “Music for Mushrooms.” Thanks to the Recorder for mentioning SSDP in the Weekly Recorder. Read more here.
We are impressed by our Board Member, Axel Bilbao, for his honest and authentic sharing of his personal journey on the Church & Other Drugs podcast. Tune into Episode 1 of Axel’s featured podcast appearances here.
We are grateful to Psychedelics Today for educating the community about the importance of DOI & DOC. “I have many colleagues who work with these compounds who will testify in the upcoming hearing, and that is only a subset of the research community,” said Elijah Ullman, Chair of SSDP’s Science Policy Council who has been interested in science policy since
In a significant development for psychedelics research, a Drug Enforcement Administration (DEA) administrative law judge has rejected the agency’s request to block key witnesses and evidence in an upcoming hearing. The case, set for November, challenges the DEA’s proposed ban on two psychedelic compounds, DOI and DOC, which are used in research. Thank you to Benzinga for sharing this important the DOI and DOC hearing news.
“Science prevails!” SSDP Executive Director Kat Murti told Marijuana Moment on Monday. “The DEA is trying to force medical research into the dark ages by criminalizing DOI and DOC—essential research chemicals in pre-clinical psychiatry and neurobiology whose status as unscheduled compounds has made them de facto tools for researchers studying serotonin receptors.” “SSDP is proud to have brought together the
Published on October 7, 2024 in Investors Hangout by Owen Jenkins. The Drug Enforcement Administration (DEA) has caused quite a stir by denying testimony from important witnesses just before scheduled hearings on the potential classification of two psychedelic compounds, 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC). This decision has led to significant backlash from advocates, most notably the Students for Sensible Drug Policy
Coverage on October 7, 2024 in Benzinga by Juan Spínelli. “What is the DEA so scared of that these leading scientists must be muzzled?” asked Robert Rush, a Denver-based attorney representing SSDP. He criticized the agency for attempting to block testimony from some of the world’s foremost experts in neuroscience and pharmacology. Read more in Benzinga here.
We are grateful to Debra Borchardt from Green Market Report for her coverage on the DOI/DOC hearings published on October 4, 2024. “What is the DEA so scared of that these leading scientists must be muzzled?” said Robert Rush, a Denver-based attorney who is working hand-in-hand with SSDP to keep research using DOI and DOC legal. “By trying to silence